AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2024
Feb 16, 2024
29821_dirs_2024-02-16_492328d8-67d8-4f8e-a7b0-5ca9e08c0777.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2024-02-14
Reporting Person: Fitzgerald Joseph Michael (EVP & Group Pres, Cardiology)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-14 | Common Stock | M | 4362.0000 | $0.0000 | Acquired | 188716.0000 | Direct |
| 2024-02-14 | Common Stock | F | 1990.0000 | $65.9500 | Disposed | 186726.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-02-14 | Restricted Stock Units | $ | M | 4362.0000 | Disposed | 2027-02-14 | Common Stock (4362.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 67974.0000 | Indirect |
| Common Stock | 4894.0000 | Indirect |
Footnotes
F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3: The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.
F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.